Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB vs ELVITEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELRANATAMAB vs ELVITEGRAVIR: Safety Overview

Metric ELRANATAMAB ELVITEGRAVIR
Total FAERS Reports 758 211
Deaths Reported 177 8
Death Rate 23.4% 3.8%
Hospitalizations 482 33
Average Patient Age 67.6 yrs 42.4 yrs
% Female Patients 45.2% 38.8%
FDA Approval Date N/A Sep 24, 2014
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription Discontinued